The imperative of fridge-free vaccines
European Pharmaceutical Review
DECEMBER 19, 2023
This requires the development of technologies to rapidly produce effective, safe, stable vaccines that can be manufactured and distributed quickly. Guaranteeing resilience in vaccine manufacturing The use of foreign materials that require removal before injection are also impracticable. at 100°C for 24 hours.
Let's personalize your content